This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
Menu

Katsuto Tamai, M.D, PhD
CSO and Director of StemRIM Inc. and Guest Professor at Osaka University Graduate School of Medicine
Speaker

Profile

1990-1996 Instructor, Department of Dermatology, Hirosaki University School of Medicine, Japan, 1996-1999 Assistant Professor, Department of Dermatology, Hirosaki University School of Medicine, 1990-2003 Associate Professor, Department of Dermatology, Hirosaki University School of Medicine, 2003-2010 Associate Professor, Department of Gene Therapy Science, Osaka University Graduate School of Medicine, Japan, 2010-2022 Professor, Department of Stem Cell Therapy Science, Osaka University Graduate School of Medicine, 2023- Director and Chief Scientific Officer, StemRIM Inc, Japan.

Agenda Sessions

  • Development of novel modality peptide drug: tissue regeneration-inducing medicine

    , 5:00pm
    View Session

At this event

Prev
Next
Sridhar Vaddeboina, Ph.D.
Vice President, Analytical Development
Wave Life Sciences

See Katsuto at TIDES Asia: Oligonucleotide & Peptide Therapeutics